Skip to content

    HIV & AIDS Health Center

    Font Size
    A
    A
    A

    Egrifta Approved for HIV-Related Lipodystrophy

    Daily Injection Treats Side Effect of Many AIDS Drugs
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    Nov. 11, 2010 -- The FDA has approved Egrifta for the treatment of HIV lipodystrophy.

    Egrifta is administered by daily injection. In clinical trials, it significantly reduced the disfiguring fat accumulation -- lipodystrophy -- that is a side effect of many AIDS drug combinations.

    "The FDA recognizes the need for therapies to treat patients with HIV-lipodystrophy," says Curtis Rosebraugh, MD, MPH, director of the FDA's Office of Drug Evaluation, in a news release. "The presence of excess fat with this condition may contribute to other health problems as well as affect a patient’s quality of life, so treatments that demonstrate they are safe and effective at treating these symptoms are important."

    While the drug is effective, it's not without side effects of its own. These include joint pain, redness and rash at the site of injection, stomach pain, swelling, and muscle pain. The drug may also cause increases in blood sugar.

    It's not clear whether Egrifta can prevent heart disease linked to HIV lipodystrophy. But compelling testimony by AIDS patients last May led an FDA expert advisory panel to unanimously recommend approving the drug.

    Egrifta was developed by Montreal-based Theratechnologies and is marketed in the U.S. by Serono.

    Today on WebMD

    misconception
    How much do you know?
    contemplative man
    What to do now.
     
    research
    Should you be tested?
    HIV under microscope
    What does it mean?
     
    HIV AIDS Screening
    Slideshow
    man opening condom wrapper
    Quiz
     
    HIV AIDS Treatment
    Feature
    Discrimination Stigma
    Feature
     
    Treatment Side Effects
    Feature
    grilled chicken and vegetables
    Article
     
    obese man standing on scale
    Article
    cold sore
    Article